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Introduction: We have recently used extracorporeal membrane oxygenation
as a means of rapidly resuscitating pediatric patients with heart disease
after cardiopulmonary arrest, in whom conventional resuscitation mea-
sures have failed. Methods: We developed a fully portable extracorporeal
membrane oxygenation circuit that is maintained vacuum and carbon
dioxide–primed at all times. When needed, the circuit is crystalloid-primed
and can be ready for use within 15 minutes. Since February 1996, we have
used this rapid-deployment circuit to resuscitate 11 pediatric patients in
full cardiopulmonary arrest. Results: The median age of the 11 patients was
120 days (2 days to 4.6 years). Nine patients had a cardiac arrest after
cardiac surgery. One patient had a cardiac arrest during cardiac catheter-
ization and one patient had a cardiac arrest before cardiac surgery. Median
duration of cardiopulmonary resuscitation was 55 minutes (range 20 to 103
minutes), with no difference in the duration of cardiopulmonary resuscita-
tion between survivors and nonsurvivors. Ten of 11 patients (91%) were
weaned from extracorporeal membrane oxygenation and seven (64%)
survived to hospital discharge. Six patients are long-term survivors, five of
whom are in New York Heart Association class I; one survivor is in class II.
Seven patients resuscitated with extracorporeal membrane oxygenation
before the use of this rapid-deployment circuit had a median duration of
cardiopulmonary resuscitation of 90 minutes, with two (28.6%) survivors.
Conclusions: The use of rapid-deployment extracorporeal membrane oxy-
genation results in shorter resuscitation times and improved survival in
pediatric patients with heart disease after cardiopulmonary arrest.
(J Thorac Cardiovasc Surg 1998;116:305-11)
Cardiac arrest may complicate the course of anychild with cardiac disease, particularly in the
postoperative period after heart surgery for con-
genital heart disease. These children represent
the most critically ill subset of an already chal-
lenging patient population. Conventional basic
and advanced cardiopulmonary resuscitation
(CPR) in adults and children has often yielded
dismal results. Mechanical circulatory support has
been used in adult patients with cardiac arrest in
a number of settings but without significant im-
provement in outcome.1-3
The use of extracorporeal membrane oxygen-
ation (ECMO) to resuscitate children having a
cardiac arrest after cardiac surgery has demon-
strated better results than in many other patient
groups.4, 5 In our institution the subset of pediat-
ric patients with cardiac disease requiring ECMO
for cardiac arrest demonstrated survivals compa-
rable with those for all pediatric patients with
heart disease requiring ECMO, for all other indi-
cations.6 These results suggest that cardiac arrest
in pediatric patients with cardiac disease may be
due to reversible conditions that can be success-
fully treated with ECMO support. This report
details our approach using a modified ECMO
circuit and an organized team to facilitate the
rapid resuscitation of pediatric patients with heart
disease after cardiac arrest.
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Methods
Patient population and statistical analysis. A retro-
spective chart review was undertaken of 11 pediatric
patients with heart disease who were treated with rapid-
resuscitation ECMO beginning in February 1996. All
children were in full cardiopulmonary arrest, receiving
CPR at the time of ECMO cannulation. The charts from
seven patients who were resuscitated with ECMO after
having a cardiac arrest before the use of this rapid-
deployment circuit were reviewed for comparison of hos-
pital course and outcome. These historical control pa-
tients were resuscitated with the standard ECMO circuit
before February 1996 and were included in a previous
analysis of the hospital course of pediatric patients with
cardiac disease undergoing mechanical circulatory sup-
port.6 Follow-up data were obtained by telephone inter-
view with parents and pediatricians of these patients after
written informed consent was obtained from the parents.
All data procurement and patient follow-up were carried
out after institutional approval according to guidelines
established by the Committee for Human Experimenta-
tion of Children’s Hospital.
Data were analyzed with a statistical program (JMP
Software, SAS Institute, Inc., Cary, N.C.). Comparison of
the duration of CPR between survivors and nonsurvivors
of the rapid-resuscitation group and between the rapid-
resuscitation group overall and historical controls was
made with the Wilcoxon two-group test. Comparisons
between survivals for the rapid-resuscitation group and
historical controls was performed with Pearson’s x2 test.
Confidence limits (CL) listed for proportions (see Results)
are equivalent to one standard error.
Components of the rapid-resuscitation ECMO circuit.
Our standard ECMO setup has been previously de-
scribed.6, 7 The rapid-resuscitation circuit is modified to
allow the institution of support within 15 minutes of
notification of its need. Maintained in the intensive care
unit on a cart with a portable, battery power supply, the
circuit is completely mobile and can be wheeled to any
location in the hospital. The circuit is maintained with a
vacuum and carbon dioxide–primed 0.8 m2 membrane
oxygenator (Avecor Cardiovascular, Inc., Plymouth,
Minn.) in line. This oxygenator is capable of supporting
flows of 1.2 L/min suitable for children up to 10 kg. For
larger children up to 25 kg, a 1.5 m2 membrane is spliced
into the circuit (1.8 L/min maximum flow rate).
When needed for resuscitation of patients who have
postoperative cardiac arrest, direct aortic and atrial can-
nulation through the chest usually provides the most
expeditious means of instituting support while allowing
the performance of effective, open CPR. In patients who
have had cardiac arrest in settings other than the postop-
erative period, femoral or neck cannulation is performed
at the discretion of the surgeon. The rapid-resuscitation
circuit is Normosol solution (Abbott Laboratories, Abbott
Park, Ill.) primed with 50 ml of 5% albumin and de-
bubbled at the bedside. Normosol solution has been
substituted for the standard saline prime in the rapid-
resuscitation circuit to minimize electrolyte disturbances
with the institution of support. The circuit is connected to
the cannulas and ECMO support is initiated.
Addition of blood components. When deployment of
the rapid-resuscitation ECMO circuit is requested, the
blood bank is also notified to procure blood products for
addition to the circuit. If blood products are not available
when cannulation is complete, support is initiated with the
crystalloid primed circuit and then 200 ml of packed red
blood cells, 100 ml of fresh frozen plasma, and 2 units of
cryoprecipitate are added to the circuit when available.
For those patients who have support instituted with a
crystalloid primed circuit, blood is usually available for
addition to the circuit within 15 to 60 minutes of the
institution of support. Blood is then added to the circuit
and crystalloid volume is removed by means of a one-for-
one syringe exchange transfusion. We use the Amicon
ultrafiltration system (W. R. Grace and Co., Beverly,
Mass.) to further remove crystalloid volume as blood
products are added, once hemodynamics on support have
stabilized.
Rapid-resuscitation ECMO team. In our institution,
ECMO is managed by the Respiratory Care Department,
which provides personnel in the hospital at all times for
the institution of urgent ECMO support. One in-house
respiratory therapist carries the “priming beeper.” If a
pediatric patient with heart disease has a cardiac arrest
and does not respond to standard resuscitative measures
after 10 minutes, a cardiologist or cardiac surgeon initiates
a call for rapid-resuscitation ECMO. Respiratory care
personnel transport the circuit to the patient’s bedside
and initiate priming. On-call members of cardiac surgery,
cardiology, and cardiac nursing are also notified that
emergency ECMO is required. Cardiac surgeons perform
all ECMO cannulations for patients with heart disease in
our institution. Once support is instituted, members of the
Respiratory Care Department continue to manage the
circuit.
Results
Demographics and setting of support. Demo-
graphic data for the patients treated with rapid-
resuscitation ECMO are listed in Table I. Seven of
the 11 patients were less than 1 year of age and three
of the 11 were less than 30 days of age. Nine of the
11 patients had support instituted in the postopera-
tive period (Table II). Patient 2, with pulmonary
atresia and an intact ventricular septum, had sudden
Table I. Patient characteristics
Sex
M 8
F 3
Age 120 days (2 days–4.6 yr)
Weight (kg) 4.9 (2.5–15.6)
Time after operation (hr) (n 5 9) 10 (2–192)
Duration of ECMO (hr) 65 (2–210)
Days chest open 6.5 (0–27)
Days intubated 13.5 (4–78)
Total hospital days 29.5 (10–65)
Median values are listed with ranges in parentheses.
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ventricular fibrillation during an otherwise stable
preoperative course. After stabilization and diag-
nostic cardiac catheterization on ECMO, the patient
was transported to the operating room where con-
version to standard cardiopulmonary bypass for
surgical repair was performed. Because of postop-
erative hypoxia, ECMO was continued by means of
chest cannulation. The patient was subsequently
weaned and survived. Patient 6, with tetralogy of
Fallot and pulmonary atresia, had support instituted
in the cardiac catheterization laboratory after car-
diac arrest caused by hypoxia while aortopulmonary
collaterals were being coiled. This patient was resus-
citated with ECMO and eventually discharged, with
definitive repair being performed during a subse-
quent hospitalization. The diagnoses of the seven
historical control patients included ventricular sep-
tal defect with aortic coarctation, tricuspid atresia,
transposition of the great arteries, transposition of
the great arteries with ventricular septal defect,
severe mitral regurgitation after repair of a transitional
atrioventricular canal, total anomalous pulmonary ve-
nous return, and complete atrioventricular canal.
Nonsurvivors. Patient 3, who had hypoplastic left
heart syndrome, had ventricular failure and cardiac
arrest after a Norwood procedure (Table II). This
patient was successfully resuscitated with ECMO
and was eventually weaned from support. However,
the patient subsequently died of multisystem organ
failure after cardiac transplantation. Patient 5 had a
cardiac arrest caused by progressive left ventricular
failure after mitral valve repair. After resuscitation
with ECMO the patient was unable to be weaned
from support and underwent cardiac transplanta-
tion. A mycotic aneurysm of the aortic anastomosis
of the cardiac allograft subsequently developed and
caused the patient’s death. Patient 10, an infant with
multiple congenital anomalies, had sudden cardiac
arrest the night after repair of tetralogy of Fallot,
presumably caused by arrhythmia. During cannula-
tion, open cardiac compressions were discontinued
for substantial lengths of time. This resulted in
severe hypoxic damage to all organ systems, and
ECMO was electively discontinued the following
day. This was the only patient in this series who
could not be successfully weaned from ECMO.
Patient 11 had a sudden cardiac arrest after truncus
arteriosus repair, possibly caused by a pulmonary
hypertensive crisis. ECMO was instituted and even-
tually weaned successfully; however, within 24 hours
of discontinuing ECMO supersystemic pulmonary
artery pressures developed and failed to respond to
conventional measures. ECMO was again instituted
via neck cannulation for an additional 6 days, after
which overwhelming mediastinal sepsis developed,
resulting in the patient’s death. Patient 9 represents
the only late death in this series. This patient was
born with hypoplastic left heart syndrome and un-
derwent cardiac transplantation for progressive ven-
tricular dysfunction at 3 years of age after a Nor-
wood procedure and a subsequent bidirectional
Glenn shunt. This patient had a cardiac arrest
during an episode of severe rejection and was
successfully weaned from ECMO after treatment of
the rejection episode. The patient was discharged
from the hospital with mild hypoxic encephalopathy,
Table II. Diagnoses, procedures, and outcomes
Patient Setting
Age
(days)
Weight
(kg) Diagnosis Procedure Outcome
1 Postop. 207 4.9 DORV-VSD Baffle of VSD to aorta Survived
2 Preop. 5 2.9 PA-IVS TAP, right MBTS Survived
3 Postop. 2 4.5 HLHS Norwood procedure Died
4 Postop. 12 2.9 Heterotaxy, PA Left MBTS Survived
5 Postop. 567 10.5 Mitral regurgitation Mitral valve repair Died
6 Cath. lab. 1667 15.6 TOF-PA Coiling of aortopulmonary collaterals Survived
7 Postop. 109 4.9 Transitional AV canal Patch closure of ASD, VSD;
mitral valve repair
Survived
8 Postop. 631 10.5 Corrected TGA, PA IVC-TV baffle; VSD-aorta baffle;
RV-PA conduit
Survived
9 Postop. 1120 12.0 Rejection Status post cardiac transplantation Late death
10 Postop. 58 2.5 TOF TOF repair (VSD closure; TAP) Died
11 Postop. 39 3.3 Truncus arteriosus Truncus arteriosus repair
(VSD closure, RV-PA conduit)
Died
DORV, Double-outlet right ventricle; VSD, ventricular septal defect; PA, pulmonary atresia; IVS, intact ventricular septum; TAP, transannular patch; MBTS,
modified Blalock-Taussig shunt; HLHS, hypoplastic left heart syndrome; TOF, tetralogy of Fallot; AV, atrioventricular; ASD, atrial septal defect; TGA,
transposition of the great arteries; IVC, inferior vena cava; TV, tricuspid valve; RV-PA, right ventricle–pulmonary artery.
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but disseminated lymphoma eventually developed,
resulting in death.
Sites of cannulation. Seven patients were cannu-
lated through the chest in the immediate postoper-
ative period. Patient 8 had a cardiac arrest the night
of operation after a complex reconstruction for
corrected transposition of the great arteries with
pulmonary atresia and was cannulated through the
chest. This patient subsequently received a left
ventricular assist device after a successful resuscita-
tion and a brief period (2 hours) of ECMO support.
Patient 11 was cannulated through the chest in the
immediate postoperative period and was success-
fully weaned from ECMO but was recannulated via
the neck on postoperative day 8 as discussed above.
Patients 4 and 9 had a cardiac arrest 10 and 8 days
after cardiac surgery, respectively, and were cannu-
lated through the neck. Patient 2 was cannulated
preoperatively through the neck and was recannu-
lated through the chest for postoperative support as
detailed above. Patient 6 had ECMO initiated in the
cardiac catheterization laboratory via sheaths in the
femoral vessels while neck cannulation was being
performed and was subsequently converted to neck
cannulation.
Complications. Cardiovascular complications
(Table III) developed in two patients who required
cardiac transplantation owing to lack of return of
native cardiac function on ECMO and in two pa-
tients with significant ventricular ectopy. The three
pulmonary complications included pulmonary in-
farction, pulmonary hemorrhage, and pneumotho-
rax in one patient each. The gastrointestinal com-
plications included upper gastrointestinal tract
hemorrhage resulting from gastritis, nutritional fail-
ure necessitating gastrostomy tube placement, and
unexplained chronic elevation of enzyme levels on
liver function tests. Two patients had renal failure
necessitating dialysis. One of these patients had
recovery of renal function by the time of hospital
discharge, but in the other patient renal function did
not recover before death. Neurologic complications
occurred in four patients: two had mild hypoxic
encephalopathy, one had choreoathetosis, and one
patient had seizures. The single mechanical compli-
cation was due to dislodgment of the aortic cannula
30 minutes after support was initiated. The patient
was quickly recannulated successfully.
Outcome. Fig. 1 compares the median duration
of CPR in patients receiving rapid-resuscitation
ECMO with seven historical control patients resus-
citated with a standard ECMO circuit before 1996.
The median duration of CPR was 55 minutes (range
20 to 103 minutes) for the rapid-resuscitation group
and 90 minutes (range 45 to 200 minutes) for the
historical controls. The duration of CPR was over 30
minutes less with the rapid-resuscitation approach
(p 5 0.085). The durations of CPR for survivors (58
minutes, range 25 to 103 minutes) and nonsurvivors
(51 minutes, range 20 to 83 minutes) in the rapid-
resuscitation group were not significantly different
(p 5 0.63). Fig. 2 compares the outcomes between
the rapid-resuscitation group and the historical con-
trols. A single patient in the rapid-resuscitation
group could not be weaned from ECMO. The
hospital survival in the rapid-resuscitation group
(7/11 survivors; 64%; CL 45% to 81%) represents a
substantial improvement over that of the historical
control group (2/7 survivors; 29%; CL 10% to 55%;
p 5 0.15). Fig. 3 demonstrates the New York Heart
Association functional status in the six long-term
Fig. 1. Duration of CPR for patients resuscitated with
rapid-resuscitation ECMO since February 1996 (n 5 11)
compared with historical controls resuscitated with stan-
dard ECMO before 1996 (n 5 7).
Table III. Complications
Complication No. of Patients
Cardiovascular 4
Pulmonary 3
Gastrointestinal 3
Renal failure 2
Neurologic 4
Hemorrhage 2
Any infection 5
Positive blood cultures 3
Mediastinitis 3
Pneumonia 2
Mechanical 1
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survivors after rapid-resuscitation ECMO. All but
one survivor is in New York Heart Association class
I with one patient in class II. One of the six
long-term survivors has mild neurologic impair-
ment, and one child has moderate impairment (Fig.
4).
Prime composition and outcome. Data regarding
the composition of the ECMO prime at the time of
institution of support is available for eight of the 11
patients. Six of these eight patients had support
instituted with crystalloid solution and two had
support instituted with a blood-primed circuit. Of
the six patients who received ECMO support with a
circuit initially primed with crystalloid, five (83%)
were successfully weaned from support and four
(67%) survived to hospital discharge. Both patients
supported with a blood-primed ECMO circuit were
successfully weaned from support and one of these
patients (50%) survived to hospital discharge.
Discussion
Mechanical circulatory support for the resuscita-
tion of patients who suffer a cardiac arrest has
gained increasingly widespread use in a number of
settings.1-3, 8, 9 The application of mechanical circu-
latory support for this indication has arisen from the
dismal outcome of conventional resuscitative mea-
sures in these patients.10, 11 Despite initial enthusi-
asm for ECMO in the setting of cardiac arrest in
adults, substantial mortality persists in most re-
ports.2 However, previous reports describing
ECMO to support pediatric patients with heart
disease after a cardiac arrest suggest their outcomes
may be better, justifying an aggressive approach in
their resuscitation.4, 5 A review of the in-hospital
course of pediatric patients with heart disease
treated with mechanical circulatory support in our
institution demonstrated that the survival for pa-
tients requiring support for cardiac arrest was the
same as for all pediatric patients with heart disease
requiring ECMO support (40% survival).6
The reasons for better outcomes in pediatric
patients with heart disease may relate to witnessed
arrests in an intensive care unit setting, the use of
effective open CPR in the postoperative period, and
Fig. 3. New York Heart Association (NYHA) classifica-
tion of six long-term survivors after rapid-resuscitation
ECMO.
Fig. 4. Neurologic status of six long-term survivors after
rapid-resuscitation ECMO.
Fig. 2. Outcomes for the rapid-resuscitation ECMO
group and historical controls. Total patients undergoing
ECMO resuscitation, patients successfully weaned from
ECMO, in-hospital survivors, and long-term survivors are
demonstrated for both groups.
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a greater degree of core cooling during cardiac
arrest in children than in adults. In addition, cardiac
arrest in these children is often due to a transient
arrhythmia or other reversible cause such as pulmo-
nary hypertensive crisis. The impact of core cooling
and effective CPR is supported by the data in the
present study, in which 10 of 11 patients were
successfully weaned from ECMO with excellent
end-organ function. Only a single patient had evi-
dence of significant hypoperfusion during resuscita-
tion requiring termination of support because of
advanced end-organ failure.
We believe that the most important factor in the
successful resuscitation of these patients is the
prompt establishment of an adequate cardiac out-
put. This rapid-resuscitation approach begins with a
prompt decision to institute ECMO support in
patients who have not responded to routine resus-
citative measures after cardiac arrest. We currently
initiate a call for rapid-resuscitation ECMO for our
patients who have a cardiac arrest if CPR is unsuc-
cessful after 10 minutes. Other important compo-
nents of this approach include using a modified
ECMO circuit to facilitate rapidly instituting sup-
port and creating an organized team to minimize
response times. In our prior experience we found
that routine priming of the ECMO circuit led to
delays in the institution of support. A source of
significant delay was consistently incurred while
waiting for blood products and the subsequent
blood priming step. If blood is not available, we
currently institute support with a crystalloid-primed
circuit to establish adequate hemodynamics as
quickly as possible. The majority of the patients in
this series had support instituted with a crystalloid-
primed circuit without apparent detriment to end-
organ function. Blood is added to the circuit when it
becomes available, which is usually within 30 min-
utes of the institution of ECMO. We have not used
O negative or type-specific blood; however, if exces-
sive delays in receiving cross-matched blood occur,
the use of non-crossmatched blood products could
be considered. Ultrafiltration can be performed as
blood is added to remove crystalloid volume from
the circuit when hemodynamics have stabilized. The
organization of a rapid-response team centered
around in-house personnel who are available at all
times to perform circuit priming is also of vital
importance. As circuit priming is initiated, cardiol-
ogy, cardiac surgery, and cardiac nursing members
of the rapid-response team are notified so that
cannulation and direction of resuscitative efforts
may proceed simultaneously. With this approach,
we presently can institute support within 30 to 45
minutes of cardiac arrest in most instances.
Once support is instituted, this patient population
requires meticulous management. Temporary ven-
tricular dysfunction is often profound. We aggres-
sively monitor for left ventricular distention by
transesophageal echocardiography and left-sided
filling pressures. We incorporate a left atrial vent
into the circuit or perform balloon atrial septostomy
if left ventricular distention occurs. Balloon atrial
septostomy may be performed in the cardiac cathe-
terization laboratory or at the bedside under echo-
cardiographic guidance.12 Four patients in this se-
ries required left atrial venting and three patients
had an unrestrictive interatrial communication to
limit left ventricular distention. If left ventricular
distension is avoided, many of these patients can be
expected to require relatively brief periods of
ECMO support, as further evidence of the revers-
ible nature of the cause of cardiac arrest in the
majority of these cases. Early return of ventricular
function (within 48 to 72 hours of institution of
support) was seen in all patients who were subse-
quently weaned from ECMO and did not require
heart transplantation. This is a consistent finding
from our previous analysis.6
Shunted, single ventricle physiology does not rep-
resent a contraindication to ECMO resuscitation
after cardiac arrest. Partially occluding the shunt
during ECMO is often useful to provide balanced
pulmonary and systemic circulations. In this series,
three patients with shunted, single ventricle physiol-
ogy (pulmonary atresia, intact ventricular septum,
complex heterotaxy with single ventricle, and hypo-
plastic left heart syndrome) were successfully resus-
citated and supported. Two of these patients are
long-term survivors; the third patient was success-
fully weaned from support but died after cardiac
transplantation.
The complications and deaths in this series are an
indication of the gravity of the clinical condition of
these patients. Bleeding complications are common
in patients undergoing postoperative mechanical
circulatory support, and in our previous analysis
excessive blood loss was a risk factor for in-hospital
death.6 Mediastinal sepsis was also a common
source of morbidity and mortality in this patient
population. Two of the four deaths were the result
of mediastinal infections that were undoubtedly due
to the fact that the majority of these children were
cannulated through the chest. The development of
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percutaneous systems for femoral cannulation for
children may eliminate lengthy periods during which
the chest is open, leading to a decrease in the
incidence of mediastinitis in these patients.
Neurologic complications were less common than
might be predicted for this group of patients, attest-
ing to the importance of effective CPR and prompt
ECMO institution. We further attempt to lessen the
impact of central nervous system ischemia occurring
during resuscitation by aggressive, controlled hypo-
thermia.13 This begins at the time of cardiac arrest
by placing ice around the patient’s head during
cannulation while CPR is performed. We then
maintain patient temperature at 34° C or less during
the first 24 hours of support and avoid temperature
elevations above 37° C at any time during the first
few days of support. Long-term neurologic fol-
low-up will be necessary to determine the ultimate
functional status of these children.
Summary
Pediatric patients with heart disease appear to
represent a favorable subset of patients who have
cardiac arrest in the hospital. Apparently reversible
causes of cardiac arrest in these patients may be
quickly diagnosed and treated during brief periods
of ECMO support. The most important factor lead-
ing to a successful outcome in these children is the
prompt institution of ECMO to provide a normal
cardiac output. We have developed a portable
ECMO circuit that can be ready for the institution
of support within 15 minutes of cardiac arrest. Using
this system for resuscitation has resulted in the
survival of seven of 11 (64%) pediatric patients with
heart disease who have had a cardiac arrest.
We thank Kimberlee Gauvreau, ScD, for her invaluable
assistance in the statistical analysis of these data.
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